Skip to content

Role of Sariva root tea bag in diabeties

Role of Sariva Root(Hemidesmus indicus R.Br.)Powder in Madhumeha (Diabetes Mellitus type-2 )

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033853
Enrollment
60
Registered
2021-05-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Group A-Sariva Root powder: In this group,sariva root powder will be used by the patient orally 10gm BD.After that patient will be followed up at the interval of 15 days for 3 months. C

Sponsors

Dr Vijaylaxmi S Mishra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: HbA1c more and equal to 6.5 % BSF more and equal to 126 mg/dl BSPP more and equal to 200 mg/dl

Exclusion criteria

Exclusion criteria: 1)DM-2 with serious complications like nephropathy, retinopathy etc. 2)Patients with certain genetics syndromes which are sometimes associated with diabetes mellitus. 3)Patients having endocrinopathies, Hormonal imbalance,Carcinoma and other related complications.

Design outcomes

Primary

MeasureTime frame
symptoms like polyuria,polydypsia,Fatigue,Polyphagia,tingling sensation in sole and palm,burning sensation in palm and sole,Numbness will be reduced.Timepoint: 4weeks

Secondary

MeasureTime frame
Haematological parameters like. Fbs,pp,HbA1c,Urine examination-routine and microscopic,Lipid profile,RFT/LFT etc.Timepoint: Haematological parameters will come within the normal limit after giving proper T/T.patient is asked to follow up at the interval of 15 days for 3 months.

Countries

India

Contacts

Public ContactProf Bhuwal Ram

Institute of Medical Sciences BHU

drbhuwal@gmail.com7007593425

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026